Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesPremature ejaculation
Der Urologe, 07/02/09
Porst H - With prevalence rates of 20%–25% premature ejaculation (PE) represents the most frequent sexual dysfunction in men. Among the medications considered for PE, oral therapy with selective serotonin re-uptake inhibitors (SSRI), Dapoxetine (the first officially approved medication for PE) and topical therapy with lidocaine/prilocaine-containing medications are given priority.
Related Articles
Treatment of Premature Ejaculation in the Asia-Pacific Region: Results from a Phase III Double-blind, Parallel-group Study of Dapoxetine
The Journal of Sexual Medicine, 11/06/09
Relevance Score: 66%
Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure
Gynecological Endocrinology, 11/16/09
Relevance Score: 46%
Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species
Oncogene, 10/29/09
Relevance Score: 43%
Premature hair greying may predict reduced bone mineral density in Graves' disease
Irish Journal of Medical Science, 10/27/09
Relevance Score: 42%
In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause
Journal of Assisted Reproduction and Genetics, 10/26/09
Relevance Score: 42%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09
Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital
Urologia Internationalis, 12/18/09
Article Search
Sponsor